Evaluation of endothelial dysfunction for cardiovascular risk prediction
Keywords:
cardiovascular diseases, risks facts, vascular endothelium, risk forecasting.Abstract
Introduction: Cardiovascular diseases constitute the first death cause worldwide, reason why the identification and modification of associated risk factors constitute prioritized strategies by the World Health Organization. To have a prediction model of cardiovascular risk enriched with the evaluation of the endothelial dysfunction would influence positively in these goals.
Objectives: To identify the presence of endothelial dysfunction in patients with or without cardiovascular diseases and to determine the association between them.
Methods: An observational and descriptive cases series study was carried out in the Cardiology and Cardiovascular Surgery Center at Saturnino Lora Teaching Clinical Surgical Provincial Hospital in Santiago de Cuba, from January, 2022 to the same month, 2023, where the traditional cardiovascular risk factors and endothelial dysfunction biomarkers were analyzed as variables. Secondarily, an analytic case-control study was carried out in which multivariate binary logistic regression was applied.
Results: The presence of endothelial dysfunction associated with the onset of cardiovascular diseases was confirmed, what was evaluated through the vasodilatation index, mediated by the brachial artery flow and the fibrinogen plasmatic concentrations.
Conclusions: The clinical and epidemiological pattern of patients with or without cardiovascular diseases did not differ from that reported in the specialized literature on the base of the identification of traditional risk factors.
Downloads
References
2. Organización Panamericana de la Salud; Organización Mundial de la Salud. La carga de las enfermedades cardiovasculares Ginebra: OMS; 2021 [citado 08/04/2023]. Disponible en: https://www.paho.org/es/enlace/carga-enfermedades-cardiovasculares.
3. Semana del Corazón 2022. Montevideo: Comisión Honoraria para la Salud Cardiovascular; 2022 [citado 08/04/2023]. Enfermedades cardiovasculares. Disponible en: https://semanadelcorazon.com.uy/2022/enfermedades-cardiovasculares/
4. Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2021. La Habana: MINSAP; 2022 [citado 08/04/2023]. Disponible en: https://files.sld.cu/dne/files/2022/10/Anuario-Estadistico-de-Salud-2021.-Ed-2022.pdf
5. Organización Mundial de la Salud. Ginebra: OMS; [actualizado 17/10/2017; citado 08/04/2023]. Conferencia Mundial de la OMS sobre las Enfermedades no Transmisibles. Disponible en: https://www.who.int/es/news-room/events/detail/2017/10/16/default-calendar/who-global-conference-on-noncommunicable-diseases
6. Abohelwa M, Kopel J, Shurmur S, Ansari MM, Awasthi Y, Awasthi S. The Framingham Study on Cardiovascular Disease Risk and Stress-Defenses: A Historical Review. J Vasc Dis. 2023 [citado 23/06/2023];2(1):122-64. Disponible en: https://mdpi-res.com/d_attachment/jvd/jvd-02-00010/article_deploy/jvd-02-00010.pdf?version=1676508922
7. Roldán Schilling V, Marín Ortuño F, Pineda Rocamora J, Climent Payá VE, Martínez Martínez JG, Marco Vera P, et al. Marcadores de hipercoagulabilidad y daño endotelial en pacientes con disfunción sistólica de origen isquémico. Rev Esp Cardiol. 2001 [citado 15/08/2020];54(10):1155-60. Disponible en: https://www.revespcardiol.org/es-pdf-13019365
8. Torres Delgado JA. Capítulo 9 Estadística Descriptiva. En: Torres Delgado JA. Informática Médica. La Habana: Editorial Ciencias Médicas; 2004; t 2 Bioestadística. p. 211-305.
9. Aguayo Canela M. Cómo hacer una regresión logística con SPSS© “paso a paso” (I). Huelva: Fundación Andaluza Beturia para la Investigación en Salud; 2007 [citado 23/06/2023]. Disponible en: http://metodos-avanzados.sociales.uba.ar/wp-content/uploads/sites/216/2014/03/Regres_log_AGUAYO-otros.pdf
10. Artiles Visbal L, Otero Iglesias J, Barrios Osuna I. Metodología de la investigación para las ciencias de salud. La Habana: Editorial Ciencias Médicas; 2008.
11. Herrera de Hurtado L. Relación entre tabaquismo y las principales enfermedades no transmisibles en El Salvador. Alerta. 2021 [citado 23/06/2023];5(1):26-32. Disponible en: https://fi-admin.bvsalud.org/document/view/wy88q
12. Patterson K, Davey R, Keegan R, Freene N. Smartphone applications for physical activity and sedentary behaviour change in people with cardiovascular disease: A systematic review and meta-analysis. PLoS One. 2021 [citado 23/06/2023];16(10):e0258460. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504773/
13. Guamán C, Acosta W, Alvarez C, Benhard H. Diabetes y enfermedad cardiovascular. Rev Urug Cardiol. 2021 [citado 23/06/2023];36(1):e36104. Disponible en: www.scielo.edu.uy/pdf/ruc/v36n1/1688-0420-ruc-36-01-e401.pdf
14. Tomlinson B, Gajanan Patil N, Fok M, Kei Lam CW. Managing dyslipidemia in patients with Type 2 diabetes. Expert Opin Pharmacother. 2021;22(16):2221-34.
15. Arredondo Hortigüela OE, Zuluaga Zuluaga MC, Morales Escobar FJ, Carrasco Carracso E, Saez Jiménez R, García Pascual JN, et al. Hipertensión arterial y riesgo cardiovascular en los pacientes hipertensos del estudio IBERICAN. Farm Comunitarios. 2019 [citado 23/06/2023];11(Supl 1 Congreso Semergen SEFAC). Disponible en: https://www.farmaceuticoscomunitarios.org/es/journal-article/hipertension-arterial-riesgo-cardiovascular-pacientes-hipertensos-del-estudio
16. Castro Quintanilla DA, Rivera Sandoval N, Solera Vega A. Síndrome metabólico: generalidades y abordaje temprano para evitar riesgo cardiovascular y diabetes mellitus tipo 2. Revista Médica Sinergia. 2023 [citado 23/06/2023];8(2):e960. Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/960/2070
17. Carvajal Carvajal C. El endotelio: estructura, función y disfunción endotelial. Med. Leg. Costa Rica. 2017 [citado 07/03/2022];34(2). Disponible en: https://www.scielo.sa.cr/pdf/mlcr/v34n2/1409-0015-mlcr-34-02-90.pdf
18. González Rey T, Savon Martin LM, Travieso Pérez SM, Maurisset Cintero Y. Disfunción endotelial en una etapa precoz del diagnóstico de hipertensión arterial. Rev. Cuban. Med. 2020 [citado 07/03/2022];59(2):e1363. Disponible en: https://www.medigraphic.com/pdfs/revcubmed/cm-2020/cm202d.pdf
19. Delgado Butrón C, Delgado Torres C, Delgado Torres L. Diabetes Mellitus y Disfunción Endotelial. Diagnóstico. 2020 [citado 04/01/2023];59(3):154-61. Disponible en: http://142.44.242.51/index.php/diagnostico/article/view/243
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
![Secimed](/templates/images/secimed.png"){kind=small}
Guidelines for authors
